The FDA in the past has not
required pharmaceutical manufacturers to prove the elixirs, which have been sold for decades, work in children, allowing dosing to be gleaned from adult data.
Not exact matches
Tracking technology in the form of barcodes or RFID chips can establish a data trail that allows companies to follow each lot from
manufacturer to pharmacy shelf, and as of 2013, tracking of
pharmaceuticals throughout the supply chain is
required as per the Drug Quality and Security Act.
The TPP
requires parties to provide a «pre-approval» procedure for patented
pharmaceuticals, with two options: 1) provide notice to a patent holder if a competitor applies to market an identical or similar drug during the patent term, along with an opportunity to seek a legal remedy such as a preliminary injunction before the generic drug is marketed; or 2) preclude marketing approval for a drug that is subject to another person's patent, unless the patent holder or original drug
manufacturer consents.
Although this may constitute negligence, the defective product claims and
pharmaceutical liability laws that govern defective drug cases do not
require plaintiffs to show that the
manufacturers and / or distributors of these drugs acted negligently.